Skip to Main Content

Paper Details

Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer.
Mod Pathol
52
2021
Author NameAffiliation
Ezra E W CohenMoores Cancer Center, university of california san diego Health
Lisa LicitraFondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Ramona F SwabyMerck & Co., Inc.
  • 1 - 3

Datasets

Release 1.2